The Link between Serum Omentin Level and Insulin Resistance Biomarkers, Lipid Profile, and Atherogenic Indices in Iraqi Obese Patients.
Keywords:Atherogenic Index of Plasma, Insulin resistance, Lipid profile, Obesity, Omentin, Triglyceride to Glucose index
Omentin (or intelectin) is a main visceral fat secretory adipokine. There is a growing interest to link omentin, obesity and co-morbidity factors. The aim of the present study is to evaluate serum omentin and its association to insulin resistance biomarkers, lipid profile and atherogenic indies. This cross – sectional study was conducted in Obesity Research and Therapy Unit-Alkindy College of Medicine by recruiting (115) individuals; 49 males /66 females. Subjects between (20 to 60) years of age were selected and classified into two groups according to their Body mass index (BMI). Group1 involved healthy lean volunteers (25 male/ 36 female; BMI 18.5 - 24.9). Group2 involved obese subjects; (24 male / 36 female with BMI ≥ 30). The study shows that obese group has higher omentin levels compared to the healthy lean group (15.49 ± 4.20 vs. 10.15 ± 5.04 pg/ml, P <0.001). In addition; obese group exhibited significantly higher levels waist circumference (WC), waist to hip ratio (WHR), glucose, insulin, homeostatic module of insulin resistance (HOMA2-IR) and lipid profile and lower levels of HDL-Chol (P <0.05). Omentin levels were significantly and positively correlated with WC, WHR, BMI, glucose, hemoglobin A1c, HOMA2-IR, triglyceride, total cholesterol, low density lipoproteins - cholesterol, triglyceride to glucose index (TyG index) and atherogenic index of plasma (AIP); (P< 0.05). Multiple regression analysis established that omentin levels was found to be associated with glucose, total Chol, TyG index and AIP in total population. These findings indicate that serum omentin levels are higher in obese individuals compared to lean subjects. Furthermore, omentin was linked to insulin resistance biomarkers and other risk factors indices such as AIP and TyG. Omentin can be used as a metabolic marker in obese.
Published Online First 20/7/2022
Celia M de Souza B, Yang R, Lee MI, Nicole M. Glynn, Dao-Zhan Yu, Pray J et al. Omentin Plasma Levels and Gene Expression Are Decreased in Obesity. Diabetes 1 June 2007; 56 (6): 1655–1661. https://doi.org/10.2337/db06-1506.
Ibraheem QA, Al Obaidy LHA, Nasir GA, Al Obaidi MT. Fat Mass and Obesity Association gene Polymorphism in PCOS Iraqi Women. Baghdad Sci.J 17(3(Suppl.):1103.http://dx.doi.org/10.21123/bsj.2020.17.3(Suppl.).1103
Booth A, Magnuson A, Fouts J, Foster M. Adipose tissue: an endocrine organ playing a role in metabolic regulation. Horm Mol Biol Clin Investig. 2016;26 (1): 25-42. https://doi.org/10.1515/hmbci-2015-0073.
Flehmig G, Scholz M, Klöting N, Fasshauer M, Tönjes A, Stumvoll M, et al. Identification of Adipokine Clusters Related to Parameters of Fat Mass, Insulin Sensitivity and Inflammation. PLoS ONE. 2014;9(6): e99785. https://doi.org/10.1371/journal.pone.0099785
Blüher M. Adipose Tissue Dysfunction in Obesity. Experimental and Clinical Endocrinology & Diabetes. 2009;117(06):241-250.
Elsaid N, Sadik N, Ahmed N, Fayez S, Mohammed N. Serum omentin-1 levels in type 2 diabetic obese women in relation to glycemic control, insulin resistance and metabolic parameters. J Clin Transl Endocrinol. 2018; 13:14-19. https://doi.org/10.1016/j.jcte.2018.05.003
Pan H, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract. 2010;88(1):29-33.
Choi R., Park MJ, Oh Y, Kim SH , Lee SG , Lee EH. Validation of multiple equations for estimating low-density lipoprotein cholesterol levels in Korean adults. Lipids Health Dis .2021. 20: 111 -122. https://doi.org/10.1186/s12944-021-01525-6.
Mohd Nor N, Lee S, Bacha F, Tfayli H, Arslanian S. Triglyceride glucose index as a surrogate measure of insulin sensitivity in obese adolescents with normoglycemia, prediabetes, and type 2 diabetes mellitus: comparison with the hyperinsulinemic-euglycemic clamp. Pediatric Diabetes. 2015;17(6):458-465. https://doi.org/10.1111/pedi.12303.
Sun CJ, McCudden C, Brisson D, Shaw J, Gaudet D, Ooi TC. Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia, J Endocr Soc. 2020; 4, (1). https://doi.org/10.1210/jendso/bvz010.
Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, Abrishami M, Juya M, Khodaee G, et al. Atherogenic Index of Plasma (AIP): A marker of cardiovascular disease. Med J Islam Repub Iran. 2015; Jul 25; 29:240.
Song YS, Hwang YC, Ahn HY, Park CY. Comparison of the Usefulness of the Updated Homeostasis Model Assessment (HOMA2) with the Original HOMA1 in the Prediction of Type 2 Diabetes Mellitus in Koreans. Diabetes Metab J. 2016; Aug;40(4):318-25. doi: 10.4093/dmj.2016.40.4.318.
Vu A, Sidhom M, Bredbeck B, Kosmiski L, Aquilante C. Evaluation of the relationship between circulating omentin-1 concentrations and components of the metabolic syndrome in adults without type 2 diabetes or cardiovascular disease. Diabetol Metab Syndr. 2014;6(1):4.
Niersmann C, Carstensen-Kirberg M, Maalmi H, Holleczek B, Roden M, Brenner H, et al. Higher circulating omentin is associated with increased risk of primary cardiovascular events in individuals with diabetes. Diabetologia. 2020 Feb;63(2):410-418. doi: 10.1007/s00125-019-05017-2. Epub 2019 Nov 9. PMID: 31705160.
Herder C, Kannenberg JM, Niersmann C, Huth C, Carstensen-Kirberg M, Wittenbecher C, et al. Independent and opposite associations of serum levels of omentin-1 and adiponectin with increases of glycaemia and incident type 2 diabetes in an older population: KORA F4/FF4 study. Eur J Endocrinol. 2017 Oct; 177(4): 277-286. doi: 10.1530/EJE-17-0100. Epub 2017 Jul 5. PMID: 28679518.
Blüher M. Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab. 2013;27(2):163-177.
Jassim A N, Th. Abd-Alwahab S. Assessment of Inflammasome Activity in Type 2 Diabetes Mellitus and Simple Obesity: Comparative Study. Baghdad Sci.J [Internet]. 2013Dec.1 [cited 2021Sep.15];10(4):1144-9. Available from: https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/2826
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care 2021;44 (Suppl. 1): S15–S33. https://doi.org/10.2337/dc21-S002.
El-Mesallamy H, El-Derany M, Hamdy N. Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med. 2011;28(10):1194-1200. https://doi.org/10.1111/j.1464-5491.2011. 03353.x
Abd-Elbaky A, Abo-ElMatty D, Mesbah N, Ibrahim S. Omentin and apelin concentrations in relation to obesity, diabetes mellitus type two, and cardiovascular diseases in Egyptian population. Int J Diabetes Dev Ctries. 2015;36(1):52-58.
Urbanová M, Dostálová I, Trachta P, Drápalová J, Kaválková P, Haluzíková D, et al. Serum Concentrations and Subcutaneous Adipose Tissue mRNA Expression of Omentin in Morbid Obesity and Type 2 Diabetes Mellitus: The Effect of Very-Low-Calorie Diet, Physical Activity and Laparoscopic Sleeve Gastrectomy. Physiol. Res. 2014;207-218.
Nanda B, Mahapatra S, Devi N, Swain S, Padhy RK, Rattanet R. Study of serum omentin-1 in relation to insulin resistance in type II diabetes mellitus. IOSR J Dental Med Sci. 2015;14(12):12-21.
Shabana Shahid S U, Sarwar S. The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects. Lipids Health Dis 2020, 19:73 -80. https://doi.org/10.1186/s12944-020-01248-0
Watanabe K, Watanabe R., Konii, H, Shirai R, Sato K, Matsuyama T A, et al. Counteractive effects of omentin-1 against atherogenesis. Cardiovasc Res, 2016, 110 (1): 118–128. https://doi.org/10.1093/cvr/cvw016
Hiramatsu-Ito M, Shibata R, Ohashi K, Uemura Y, Kanemura N, Kambara T, et al. Omentin attenuates atherosclerotic lesion formation in apolipoprotein E-deficient mice. Cardiovasc Res. 2016 May 1;110(1):107-17. doi: 10.1093/cvr/cvv282. Epub 2015 Dec 28. PMID: 26714927.
Al Shawaf E, Al-Ozairi E, Al-Asfar F, Mohammad A, Al-Beloushi S, Devarajan S, et al. Atherogenic Index of Plasma (AIP) a Tool to Assess Changes in Cardiovascular Disease Risk Post Laparoscopic Sleeve Gastrectomy. J Diabetes Res. 2020; 2020:1-9. https://doi.org/10.1155/2020/2091341.
Shen SW, Lu Y, Li F, Yang CJ, Feng YB, Li HW, et al. Atherogenic index of plasma is an effective index for estimating abdominal obesity. Lipids Health Dis. 2018 Dec;17(1):1-6. https://doi.org/10.1186/s12944-018-0656-1.
Hong S, Han K, Park CY. The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study. BMC Med. 2020 Dec;18(1):1-8. https://doi.org/10.1186/s12916-020-01824-2.
Mazidi M, Katsiki N, Mikhailidis DP, Banach M. The link between insulin resistance parameters and serum uric acid is mediated by adiposity. Atherosclerosis. 2018; 270:180-186. doi:10.1016/j. atherosclerosis.2017.12.033.
Copyright (c) 2022 Baghdad Science Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.